Location: Hall F-J Neuroscience 2012, SfN’s 42nd annual meeting, is scheduled for Oct. 13 -17 in New Orleans at the Ernest N. Morial Convention Center.
Presentation time: Sunday, Oct 14, 2012, 4:00 PM – 5:00 PM
Authors: *K. A. ZUKOR, S. BELIN, L. YANG, C. WANG, H. NAWABI, Z. HE;
Children’s Hosp. Boston, Boston, MA
Abstract: Deletion of the Phosphatase and tensin homolog (PTEN) gene in corticospinal tract (CST) neurons via Cre-mediated recombination dramatically enhances their intrinsic regenerative ability and enables many of them to regrow axons through and beyond a spinal cord injury (Nat Neurosci, 2010, 13: 1075). This strategy requires the recipient to have a targeted mutation that inserts loxP sites around the PTEN gene. To broaden the versatility of this treatment, we tested whether RNA interference could be used to silence PTEN rather than gene deletion. We generated an adeno-associated virus that expresses a short-hairpin RNA sequence that has been previously shown to effectively knock-down PTEN protein expression in mice (AAV-shPTEN, J Neurosci, 2011, 31:4345). We injected this virus into the motor cortex of wild type mice, analyzed axon regeneration after a full crush spinal cord injury and compared results to those obtained from PTEN floxed/floxed mice injected with a virus expressing Cre (positive control) and appropriate negative controls. Whereas few to no axons were seen beyond the lesion in negative control mice, robust regeneration was seen in many of the animals injected with the AAV-shPTEN virus. Amounts were similar to the amounts seen in positive control mice. These results suggest that PTEN can be effectively silenced post-transcriptionally in CST neurons to enhance intrinsic axon growth after spinal cord injury and thus, open the door for testing this strategy in mammals in which targeted mutagenesis is not possible or practical, including humans. This tool will also give us more flexibility in testing combinations of therapies aimed at boosting intrinsic growth as well as altering the lesion environment.
- Two Leading Spinal Cord Injury Experts Join ReNetX Scientific Advisory Board
- Get registered for Working 2 Walk 2017 today!
- Airline lobby wins another big delay on reporting data for wheelchair damages and losses *January 2019*
- An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling
- 17th International Symposium on Neural Regeneration
- Combinatory repair strategy to promote axon regeneration and functional recovery after chronic spinal cord injury
- Gait Rehabilitation with a Neurologically Controlled Exoskeleton
- Nanoparticles limit damage in spinal cord injury
- It’s Not a Rat’s Race for Human Stem Cells Grafted to Repair Spinal Cord Injuries
- It’s On! U2FP Working 2 Walk 2017 and SCI Curecast Episode 11
- InVivo Therapeutics restructures and suspends chronic SCI stem cell and gene therapy research programs
- Pretreatment May Unlock the Regenerative Potential of Neural Stem Cells in Chronic Spinal Cord Injury
- Regulateable Chondroitinase ABC gene therapy as a treatment for spinal cord injury
- Miracle chemical ‘cocktail’ could cure spinal cord damage
- Combined expression of pro-regenerative transcription factors and transplanted stem cells to promote corticospinal tract regeneration.
Follow on TwitterMy Tweets